COVID-19 vaccine immunity to stay at least a year: Moderna

The company's vaccine,mRNA-1273, uses synthetic mRNA to mimic the surface of the coronavirus and teach the immune system to recognize and neutralize it.

Published On 2021-01-12 05:00 GMT   |   Update On 2021-01-12 08:19 GMT

New Delhi: Immunity from Moderna Inc's COVID-19 vaccine should last at least a year, the company said on Monday at the J.P. Morgan Healthcare conference.The drugmaker said it was confident that the messenger RNA (mRNA) technology it used was well suited to deploy a vaccine based on the new variant of the coronavirus which has emerged in a handful of countries.The company's vaccine,...

Login or Register to read the full article

New Delhi: Immunity from Moderna Inc's COVID-19 vaccine should last at least a year, the company said on Monday at the J.P. Morgan Healthcare conference.

The drugmaker said it was confident that the messenger RNA (mRNA) technology it used was well suited to deploy a vaccine based on the new variant of the coronavirus which has emerged in a handful of countries.

The company's vaccine, mRNA-1273, uses synthetic mRNA to mimic the surface of the coronavirus and teach the immune system to recognize and neutralize it.

Moderna said in December it would run tests to confirm the vaccine's activity against any strain.

Read also: Moderna COVID-19 vaccine approved for use in UK

The company said on Monday it expects to deliver between 600 million doses and 1 billion doses of its vaccine in 2021 and forecast vaccine-related sales of $11.7 billion for the year, based on advance purchase agreements signed with governments.

"The team feels very comfortable with the track record we have now ... that we are on track to deliver at least 600 million doses," Chief Executive Officer Stéphane Bancel said.

Read also: COVID-19 vaccine main candidates - Where they stand



Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News